Beam Therapeutics Shares Outstanding 2019-2021 | BEAM

Beam Therapeutics shares outstanding history from 2019 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Beam Therapeutics shares outstanding for the quarter ending June 30, 2021 were 0.062B, a 25.85% increase year-over-year.
  • Beam Therapeutics 2020 shares outstanding were 0.047B, a 621.19% increase from 2019.
  • Beam Therapeutics 2019 shares outstanding were 0.006B, a 123.91% increase from 2018.
  • Beam Therapeutics 2018 shares outstanding were 0.003B, a INF% increase from .
Beam Therapeutics Annual Shares Outstanding
(Millions of Shares)
2020 47
2019 6
2018 3
Beam Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 62
2021-03-31 60
2020-12-31 47
2020-09-30 50
2020-06-30 49
2020-03-31 31
2019-12-31 6
2019-09-30 7
2019-06-30 6
2019-03-31 6
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.301B $0.000B
Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.460B 8.55
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.211B 20.68
Biohaven Pharmaceutical Holding (BHVN) United States $8.952B 0.00
Emergent Biosolutions (EBS) United States $2.717B 6.55
Arcus Biosciences (RCUS) United States $2.502B 0.00
Myovant Sciences (MYOV) United Kingdom $1.906B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.820B 0.00
Zymeworks (ZYME) Canada $1.088B 0.00
Ambrx Biopharma (AMAM) United States $0.513B 0.00
SQZ Biotechnologies (SQZ) United States $0.343B 0.00
Enzo Biochem (ENZ) United States $0.159B 15.57